NCT04968210View on ClinicalTrials.gov

Metabolic Remodeling in Pulmonary Arterial Hypertension (PAH)

CompletedOBSERVATIONAL
Enrollment

3

Participants

Timeline

Start Date

May 27, 2022

Primary Completion Date

December 17, 2024

Study Completion Date

December 17, 2024

Conditions
Pulmonary Arterial Hypertension
Interventions
DRUG

Hyperpolarized 13C-pyruvate

Use of hyperpolarized 13C-pyruvate to assess metabolic remodeling in PAH

Trial Locations (1)

75390

UT Southwestern Medical Center, Dallas

All Listed Sponsors
lead

University of Texas Southwestern Medical Center

OTHER